Care Health Insurance unlisted shares represent equity ownership in Care Health Insurance Limited, a specialist health insurer in India that is not listed on the stock exchanges. Investors evaluating Care Health Insurance unlisted shares should not look only at the quoted share price. The more important question is whether the insurer is growing premiums with underwriting discipline, stable claim ratios, adequate solvency, controlled expenses, and reasonable valuation. This blog explains how to read the business and profitability of a health insurance company before considering exposure in the pre-IPO or unlisted market.
Care Health Insurance Limited, formerly known as Religare Health Insurance, is a specialist health insurance company in India. The company operates under IRDAI registration number 148 and offers products across health insurance, travel insurance, personal accident, critical illness, group health and related insurance categories.
Since the company is not currently listed on NSE or BSE, its shares are traded in the unlisted or pre-IPO market through private transactions. This is why investors often search for terms such as Care Health Insurance unlisted shares, Care Health unlisted share price, or insurance company pre-IPO opportunities.
However, unlisted shares are different from listed shares in a few important ways:
For this reason, investors should treat the Care Health unlisted share price as only one input. The deeper analysis should focus on the quality of the underlying insurance business.
Health insurance has become one of the most important segments of India’s non-life insurance market. IRDAI’s Annual Report 2024-25 states that health insurance was the largest segment within non-life insurance, contributing more than 41% of total premium, with segment growth of around 9% during FY2024-25.
General and health insurers collected more than ₹1.17 lakh crore in health insurance premium in FY2024-25, excluding personal accident and travel insurance. The same report states that around 58 crore lives were covered under health insurance policies during the year.
This matters because standalone health insurers benefit from structural demand drivers such as:
At the same time, health insurance is not automatically a high-profit business. Medical inflation, claim frequency, hospital pricing, fraud control, reinsurance terms and customer retention all affect profitability. A health insurer can show strong premium growth and still face pressure if claim ratios or operating expenses rise faster than earned premiums.
That is why the right question is not only “What is the Care Health unlisted share price today?” A better question is: “Does the current valuation properly reflect the company’s growth, underwriting quality, capital strength and risks?”
Gross Written Premium, or GWP, is the total premium written by the insurer before reinsurance deductions. It shows the scale of business generated during the year.
For Care Health Insurance, publicly available FY2025 financial summaries show GWP of ₹8,561.99 crore, compared with ₹7,021.93 crore in FY2024 and ₹5,237.69 crore in FY2023.
A rising GWP usually indicates business growth. But it does not automatically mean profitability. An insurer can grow GWP by aggressively pricing products, expanding into low-margin group business, or paying higher distribution costs. Investors should check whether premium growth is coming with underwriting discipline.
Net Earned Premium, or NEP, is the premium that is actually earned after adjusting for reinsurance and unexpired risk. It is more useful than GWP when analysing profitability.
Care Health’s FY2025 Net Earned Premium was reported at ₹6,732.71 crore, compared with ₹6,046.67 crore in FY2024 and ₹4,590.88 crore in FY2023.
A healthy insurer should ideally show growth in both GWP and NEP. If GWP grows much faster than NEP, investors should check reinsurance dependency and retention levels.
The combined ratio is one of the most important profitability indicators for a general or health insurer.
Combined Ratio = Claims Ratio + Expense Ratio
A combined ratio below 100% usually means underwriting profit. A combined ratio above 100% indicates that claims and operating expenses exceed earned premium, meaning the insurer may depend on investment income to remain profitable.
Care Health’s FY2025 combined ratio was reported at 103%, compared with 95% in FY2024 and 92% in FY2023. This does not automatically make the company unattractive, but it signals that investors should examine why underwriting profitability weakened. Was it due to higher claims, aggressive growth, medical inflation, pricing gaps, or business mix?
Health insurance profitability is highly sensitive to claims. IRDAI data shows that the health insurance incurred claims ratio for general and health insurers remained elevated in FY2024-25, while standalone health insurers reported a lower incurred claims ratio than the broader health insurance market.
For investors, the important point is not only the claim ratio number but its trend. Rising claim frequency, higher hospital bills, lifestyle diseases and medical inflation can pressure margins.
Good signs include:
Red flags include:
The solvency ratio indicates whether an insurer has enough capital to meet policyholder obligations. IRDAI requires insurers to maintain a minimum solvency ratio of 1.50 times.
Care Health’s FY2025 solvency ratio was reported at 1.68, compared with 1.74 in FY2024 and 1.82 in FY2023. A solvency ratio above the regulatory minimum is necessary, but investors should also study the direction. A declining solvency ratio may suggest that business growth is consuming capital. This is common in expanding insurance companies, but it needs monitoring.
Insurance companies collect premiums upfront and pay claims later. During this period, they invest funds in regulated investment assets. Investment income can support overall profitability, especially when underwriting margins are thin.
Care Health’s income from investments was reported at ₹367.58 crore in FY2025, compared with ₹268 crore in FY2024 and ₹179.10 crore in FY2023. Investors should separate underwriting performance from investment returns. If profit depends heavily on investment income while the combined ratio remains above 100%, the quality of earnings needs closer review.
Health insurer valuation cannot be judged only by revenue multiples. Investors should consider:
In FY2025, Care Health’s price-to-book multiple was reported at 5.77 times, while the price-to-earnings multiple rose due to lower earnings. A high valuation may still be justified if growth, profitability and capital efficiency improve. But if earnings are volatile or underwriting pressure remains, investors should evaluate carefully before paying a premium.
Step 1: Start with industry growth
First, check whether the health insurance sector itself is expanding. Look at IRDAI annual reports, health premium growth, lives covered and segment mix. A growing industry improves the opportunity size, but it does not remove company-specific risks.
Step 2: Check premium growth quality
Review GWP and NEP together. Ask whether GWP is growing consistently, whether NEP is also growing, whether the company is retaining quality business, and whether growth is coming from retail, group, government, or corporate policies. Retail health insurance is generally more attractive if pricing is disciplined and renewals are strong. Group health insurance can scale faster but may face pricing pressure.
Step 3: Study underwriting performance
The combined ratio is central to insurance analysis. A combined ratio below 100% shows underwriting profit. A ratio above 100% means underwriting loss before investment income. For Care Health, the FY2025 combined ratio of 103% suggests investors should track whether this is temporary or part of a broader trend.
Step 4: Review claims and expense discipline
Break down profitability into claims incurred, operating expenses, commission and distribution cost, technology and servicing cost, hospital network management and fraud control. An insurer with strong premium growth but poor claims control may struggle to create shareholder value.
Step 5: Check capital adequacy
A growing insurer needs capital. If growth is strong, solvency can decline unless the company raises capital or improves profitability. Investors should check solvency ratio trend, net worth growth, capital raising history, rights issues, regulatory compliance and ability to fund growth without excessive dilution.
Step 6: Compare valuation with business quality
Do not compare share price alone. Compare valuation with fundamentals. A lower Care Health unlisted share price may not be attractive if profitability is weakening. A higher price may not be unreasonable if growth, solvency and underwriting margins are improving. The correct view depends on company performance, price paid and investor holding period.
Step 7: Build a margin of safety
Unlisted shares carry liquidity and price discovery risk. Investors should demand a reasonable margin of safety because exit timelines are uncertain. A disciplined investor should avoid buying only because of a possible IPO narrative.
| Factor | What to Check | Good Sign | Red Flag |
| Premium Growth | GWP and NEP trend | Consistent growth in both | GWP growth without NEP growth |
| Business Mix | Retail, group and government split | Higher quality retail renewals | Aggressive low-margin group growth |
| Combined Ratio | Claims plus expenses vs earned premium | Below or moving toward 100% | Sustained above 100% |
| Claims Ratio | Medical claims trend | Stable or improving claim ratio | Sharp rise in claims |
| Expense Ratio | Operating and distribution cost | Cost efficiency improves with scale | Expenses rise faster than premium |
| Solvency Ratio | Capital adequacy | Comfortably above 1.50x | Falling close to regulatory minimum |
| Investment Income | Contribution to profit | Supports earnings, not the only driver | Profit depends mainly on investment returns |
| Net Worth | Capital base | Consistent growth | Frequent dilution without profitability |
| Valuation | P/B, P/E, peer comparison | Valuation supported by fundamentals | Price driven only by IPO expectation |
| Liquidity | Exit options | Clear transfer process and demand | Wide bid-ask spread or unclear exit |
| Point | Care Health Insurance unlisted shares | Listed insurance stocks |
| Price Discovery | Private market quotes | Exchange-based live price |
| Liquidity | Limited | Usually higher |
| Information Availability | Lower than listed companies | Higher due to exchange disclosures |
| Entry Opportunity | Possible pre-IPO exposure | Public market exposure |
| Exit Flexibility | Depends on buyer availability | Can sell on exchange |
| Valuation Gap | May include pre-IPO premium or liquidity discount | Market-driven valuation |
| Risk Level | Higher due to unlisted nature | Still risky, but more transparent |
The comparison is not about which is always better. It depends on investor objective, risk appetite, time horizon, valuation comfort and access to reliable information.
Investors may consider Care Health Insurance unlisted shares when they understand both the opportunity and the risk. A decision should be based on a structured review, not only on IPO expectations.
The better approach is to ask: “Am I paying a fair price for the company’s current and expected performance?” rather than “Will this company list soon?”
1. Looking only at premium growth
Premium growth is important, but poor underwriting can destroy value. Always read GWP along with NEP, claims ratio and combined ratio.
2. Ignoring solvency
An insurer can grow fast and still require repeated capital infusion. Solvency tells you whether the company has enough capital buffer.
3. Treating unlisted price as fair value
The quoted Care Health unlisted share price is not the same as fair value. It may include demand-supply imbalance, intermediary margin, IPO expectation or low liquidity.
4. Overvaluing IPO possibility
An insurance company pre-IPO opportunity should not be bought only because it may list someday. IPO timing, pricing and approval are uncertain.
5. Ignoring dilution risk
If the company raises fresh capital before IPO, existing shareholders may face dilution depending on terms.
6. Comparing with listed peers blindly
Listed peers may have different business mix, profitability, brand strength, scale, distribution model and market liquidity. Peer comparison should be adjusted.
7. Not checking transfer process
Unlisted shares require proper documentation, demat transfer and compliance checks. Weak documentation can create operational risk.
8. Confusing customer brand with shareholder returns
A strong insurance brand is useful, but shareholder returns depend on profitability, capital efficiency and valuation paid.
Supremus Angel supports investors by helping them access information and transaction support for pre-IPO and unlisted shares in a structured manner. For companies such as Care Health Insurance, investors often need more than a quoted price. They need clarity on financial performance, valuation logic, transfer process, documentation and key risks.
Supremus Angel’s role is informational and facilitative. The platform helps investors:
Supremus Angel does not guarantee returns or listing outcomes. Investors should evaluate carefully, consider their own risk profile and consult qualified advisors where required.
1. What are Care Health Insurance unlisted shares?
Care Health Insurance unlisted shares are equity shares of Care Health Insurance Limited that are not listed on NSE or BSE. They are traded privately in the unlisted or pre-IPO market through negotiated transactions.
2. Is Care Health Insurance listed in the stock market?
No, Care Health Insurance is not currently listed on the stock exchanges. Investors interested in exposure generally look at the unlisted share market, subject to availability and transfer rules.
3. What is the Care Health unlisted share price?
The Care Health unlisted share price can vary across platforms, sellers and transaction sizes because it is not exchange-traded. Investors should verify the latest price, seller authenticity, documentation and transfer process before making any decision.
4. Is Care Health Insurance an insurance company pre-IPO opportunity?
Care Health Insurance is often discussed in the insurance company pre-IPO market because it is an unlisted health insurer. However, investors should not assume IPO timing or listing valuation. Any investment should depend on company performance and valuation.
5. How should investors analyse health insurer valuation?
Health insurer valuation should include price-to-book value, price-to-earnings, GWP growth, NEP growth, combined ratio, claims ratio, expense ratio, solvency ratio, net worth growth and peer comparison. Liquidity discount is also important for unlisted shares.
6. Why is the combined ratio important for Care Health Insurance unlisted shares?
Combined ratio shows whether the insurer is making underwriting profit. A ratio below 100% generally indicates underwriting profit, while a ratio above 100% means claims and expenses exceed earned premium. This directly affects profitability quality.
7. What is a good solvency ratio for a health insurer?
IRDAI requires insurers to maintain a minimum solvency ratio of 1.50 times. A ratio above this level is necessary, but investors should also check the trend. A falling solvency ratio may indicate that growth is consuming capital.
8. Are Care Health Insurance unlisted shares risky?
Yes, like all unlisted shares, they carry risks such as limited liquidity, uncertain exit, valuation risk, regulatory risk and company performance risk. Investors should evaluate carefully and avoid investing only on the basis of IPO expectations.
9. Can premium growth alone justify a higher valuation?
No. Premium growth must be studied with claims, expenses, combined ratio, solvency and profitability. Fast growth without underwriting discipline can weaken long-term shareholder value.
10. What should investors check before buying Care Health Insurance unlisted shares?
Investors should check the latest financials, valuation, solvency ratio, combined ratio, share transfer process, demat credit timeline, seller credibility, applicable lock-in rules and their own liquidity needs before investing.
